000 04249naaaa2200925uu 4500
001 https://directory.doabooks.org/handle/20.500.12854/56130
005 20220220060311.0
020 _abooks978-3-03928-713-0
020 _a9783039287123
020 _a9783039287130
024 7 _a10.3390/books978-3-03928-713-0
_cdoi
041 0 _aEnglish
042 _adc
100 1 _aUekusa, Hidehiro
_4auth
700 1 _aYonemochi, Etsuo
_4auth
245 1 0 _aPharmaceutical Crystals
260 _bMDPI - Multidisciplinary Digital Publishing Institute
_c2020
300 _a1 electronic resource (148 p.)
506 0 _aOpen Access
_2star
_fUnrestricted online access
520 _aThe crystalline state is the most commonly used essential solid active pharmaceutical ingredient (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines, but the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutical compounds. Crystal structure analysis provides important structural information related to the API's wide range of physicochemical properties, such as solubility, stability, tablet performance, color, and hygroscopicity. This book entitled “Pharmaceutical Crystals"" focuses on the relationship between crystal structure and physicochemical properties. In particular, the new crystal structure of pharmaceutical compounds involving multi-component crystals, such as co-crystals, salts, and hydrates, and polymorph crystals are reported. Such crystal structures were investigated in the latest studies that combined morphology, spectroscopic, theoretical calculation, and thermal analysis with crystallographic study. This book highlights the importance of crystal structure information in many areas of pharmaceutical science and presents current trends in the structure–property study of pharmaceutical crystals. The Guest Editors of this book hope the readers enjoy a wide variety of recent studies on Pharmaceutical Crystals.
540 _aCreative Commons
_fhttps://creativecommons.org/licenses/by-nc-nd/4.0/
_2cc
_4https://creativecommons.org/licenses/by-nc-nd/4.0/
546 _aEnglish
653 _acrystal structure analysis
653 _an/a
653 _afamotidine
653 _asolution crystallization
653 _asalt optimization
653 _astructure determination from powder diffraction data
653 _aHirshfeld surface analysis
653 _aDFT
653 _amolecular docking study
653 _amelting diagram
653 _adehydration
653 _ahygroscopicity
653 _aHBV
653 _aBenzodioxole
653 _apharmaceutical crystals
653 _a4-b]indol-4-one
653 _apyrimidin-4(3H)-one
653 _aliquid assisted grinding
653 _aHOMO-LUMO
653 _adissolution
653 _acocrystal formation
653 _aRaman spectroscopy
653 _acarbamazepine
653 _ahydrogen bonding
653 _a3
653 _aondansetron
653 _aphysicochemical properties
653 _asolubility
653 _asuccinic acid
653 _acocrystal
653 _aadefovir dipivoxil
653 _ahepatitis B
653 _apolymorphs
653 _ahydrogen-bond-acceptance ability
653 _aDFT study
653 _aNitrofurantoin–4-dimethylaminopyridine (NF-DMAP) salt
653 _aphotostability
653 _aon-line monitoring
653 _a5-dihydro-4H-pyrimido[5
653 _aImidazole
653 _aSemicarbazone
653 _acrystal habit
653 _aCrystal structure
653 _asolvent-mediated polymorphic transformation
653 _aticagrelor
653 _ahydrate
653 _apharmaceutical cocrystal
653 _amalonic acid
653 _a1H-indole
653 _areactivity descriptors
653 _afamoxadone
653 _acrystal structure
653 _adicarboxylic acid
653 _ahydrogen bond
653 _asaccharin
856 4 0 _awww.oapen.org
_uhttps://mdpi.com/books/pdfview/book/2162
_70
_zDOAB: download the publication
856 4 0 _awww.oapen.org
_uhttps://directory.doabooks.org/handle/20.500.12854/56130
_70
_zDOAB: description of the publication
999 _c69488
_d69488